Featured

January 10, 2023

Alto touts new PhIIa depression data with plans to keep charging forward

January 10, 2023

BioTech Nation Interview with Dr. Amit Etkin, Founder & CEO, Alto Neuroscience

October 11, 2022

Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds

January 10, 2023

Alto touts new PhIIa depression data with plans to keep charging forward

January 10, 2023

BioTech Nation Interview with Dr. Amit Etkin, Founder & CEO, Alto Neuroscience

October 11, 2022

Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds

In the News

BioTech Nation Interview with Dr. Amit Etkin, Founder & CEO, Alto Neuroscience

January 10, 2023

Alto says depression drug shows 'clear' clinical signal in biomarker-defined patients

January 10, 2023

A scientist quit Stanford to chase a new way to treat depression. He just shared an early sign that his approach could work.

January 10, 2023

Alto’s hopes for brain biomarker strategy rise on phase 2 antidepressant data

January 10, 2023

Subscription Required

Alto touts new PhIIa depression data with plans to keep charging forward

January 10, 2023

Top Life Sciences Startups to Watch in 2023

January 4, 2023

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Receive updates from Alto

Thanks for signing up!

Oops! Something went wrong while submitting the form.

© Alto Neuroscience 2023
‍